Gene Review:
SEMA3F - sema domain, immunoglobulin domain (Ig),...
Homo sapiens
Synonyms:
SEMA-IV, SEMA4, SEMAK, Sema III/F, Sema IV, ...
- Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Kusy, S., Nasarre, P., Chan, D., Potiron, V., Meyronet, D., Gemmill, R.M., Constantin, B., Drabkin, H.A., Roche, J. Neoplasia (2005)
- Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Nasarre, P., Kusy, S., Constantin, B., Castellani, V., Drabkin, H.A., Bagnard, D., Roche, J. Neoplasia (2005)
- Neuropilins in neoplasms: expression, regulation, and function. Bielenberg, D.R., Pettaway, C.A., Takashima, S., Klagsbrun, M. Exp. Cell Res. (2006)
- Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Osada, R., Horiuchi, A., Kikuchi, N., Ohira, S., Ota, M., Katsuyama, Y., Konishi, I. Hum. Pathol. (2006)
- Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. Bielenberg, D.R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C.C., Klagsbrun, M. J. Clin. Invest. (2004)
- Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M.I., Gazdar, A.F., Minna, J.D. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Sekido, Y., Bader, S., Latif, F., Chen, J.Y., Duh, F.M., Wei, M.H., Albanesi, J.P., Lee, C.C., Lerman, M.I., Minna, J.D. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Nasarre, P., Constantin, B., Rouhaud, L., Harnois, T., Raymond, G., Drabkin, H.A., Bourmeyster, N., Roche, J. Neoplasia (2003)
- Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Xiang, R., Davalos, A.R., Hensel, C.H., Zhou, X.J., Tse, C., Naylor, S.L. Cancer Res. (2002)
- Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. Brambilla, E., Constantin, B., Drabkin, H., Roche, J. Am. J. Pathol. (2000)
- Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. Kusy, S., Potiron, V., Zeng, C., Franklin, W., Brambilla, E., Minna, J., Drabkin, H.A., Roche, J. Biochim. Biophys. Acta (2005)
- Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Giger, R.J., Urquhart, E.R., Gillespie, S.K., Levengood, D.V., Ginty, D.D., Kolodkin, A.L. Neuron (1998)
- KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Dekker, R.J., Boon, R.A., Rondaij, M.G., Kragt, A., Volger, O.L., Elderkamp, Y.W., Meijers, J.C., Voorberg, J., Pannekoek, H., Horrevoets, A.J. Blood (2006)
- Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. Lantuéjoul, S., Constantin, B., Drabkin, H., Brambilla, C., Roche, J., Brambilla, E. J. Pathol. (2003)